**Core Concept**
Glycopeptide antibiotics are a class of **bacteriocidal** drugs that inhibit cell wall synthesis in bacteria. They are primarily used against **Gram-positive** bacteria, including **methicillin-resistant Staphylococcus aureus (MRSA)**.

**Why the Correct Answer is Right**
The correct answer is not provided, however, common glycopeptide antibiotics include **vancomycin** and **teicoplanin**. These drugs work by binding to the **D-alanyl-D-alanine** terminus of cell wall precursors, preventing the action of **transpeptidase** and **transglycosylase** enzymes.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific option provided, it's challenging to give a precise reason.
**Option B:** Similarly, without details, it's hard to explain.
**Option C:** This option would be incorrect if it were a known glycopeptide antibiotic.
**Option D:** Same as above, lacking specifics makes it difficult to address directly.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **vancomycin** is a glycopeptide antibiotic often used as a last resort against **MRSA** and other resistant **Gram-positive** infections. Monitoring of **vancomycin** levels is crucial to avoid **nephrotoxicity**.

**Correct Answer:** Not provided in the query.